384 related articles for article (PubMed ID: 24320102)
1. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
[TBL] [Abstract][Full Text] [Related]
3. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
4. Reproductive function assessment after surgery plus chemotherapy for germ cell ovarian tumors (MOGCT): novel clues deriving from the field of fertility preservation.
Ottolina J; Mangili G; Sigismondi C; Vanni VS; Viganò P; Candiani M
Gynecol Endocrinol; 2014 Nov; 30(11):778-80. PubMed ID: 25034573
[TBL] [Abstract][Full Text] [Related]
5. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
[TBL] [Abstract][Full Text] [Related]
6. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
[TBL] [Abstract][Full Text] [Related]
7. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
8. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
[TBL] [Abstract][Full Text] [Related]
9. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
[TBL] [Abstract][Full Text] [Related]
10. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
11. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
13. Fertility sparing surgery in malignant ovarian Germ cell tumor (MOGCT): 15 years experiences.
Zamani N; Rezaei Poor M; Ghasemian Dizajmehr S; Alizadeh S; Modares Gilani M
BMC Womens Health; 2021 Aug; 21(1):282. PubMed ID: 34348686
[TBL] [Abstract][Full Text] [Related]
14. Reproductive function after treatment of ovarian germ cell malignancy.
Anita AN; Rushdan MN
Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552
[TBL] [Abstract][Full Text] [Related]
15. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
Gadducci A; Lanfredini N; Tana R
Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
[TBL] [Abstract][Full Text] [Related]
16. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS
Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051
[TBL] [Abstract][Full Text] [Related]
17. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors.
Zhang N; Chen R; Hua K; Zhang Y
J Ovarian Res; 2017 Jul; 10(1):52. PubMed ID: 28750644
[TBL] [Abstract][Full Text] [Related]
19. The significance of comprehensive staging surgery in malignant ovarian germ cell tumors.
Liu Q; Ding X; Yang J; Cao D; Shen K; Lang J; Zhang G; Xin X; Xie X; Wu Y
Gynecol Oncol; 2013 Dec; 131(3):551-4. PubMed ID: 24007946
[TBL] [Abstract][Full Text] [Related]
20. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.
Li J; Wu X
Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
